120 related articles for article (PubMed ID: 32412073)
1. An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program.
Tran Q; Warren JL; Barrett MJ; Annett D; Marth M; Cress RD; Deapen D; Glaser SL; Gomez SL; Schwartz SM; Li CI; Wu XC; Enewold L; Harlan LC; Rivera DR; Winn DM; Penberthy L; Cronin KA
J Natl Cancer Inst Monogr; 2020 May; 2020(55):72-81. PubMed ID: 32412073
[TBL] [Abstract][Full Text] [Related]
2. Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results.
Du X; Freeman JL; Goodwin JS
J Clin Epidemiol; 1999 May; 52(5):463-70. PubMed ID: 10360342
[TBL] [Abstract][Full Text] [Related]
3. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
Warren JL; Klabunde CN; Schrag D; Bach PB; Riley GF
Med Care; 2002 Aug; 40(8 Suppl):IV-3-18. PubMed ID: 12187163
[TBL] [Abstract][Full Text] [Related]
4. Development and Evaluation of a Process to Link Cancer Patients in the SEER Registries to National Medicaid Enrollment Data.
Warren JL; Benner S; Stevens J; Enewold L; Huang B; Zhao L; Tilahun N; Bradley CJ
J Natl Cancer Inst Monogr; 2020 May; 2020(55):89-95. PubMed ID: 32412075
[TBL] [Abstract][Full Text] [Related]
5. Studying radiation therapy using SEER-Medicare-linked data.
Virnig BA; Warren JL; Cooper GS; Klabunde CN; Schussler N; Freeman J
Med Care; 2002 Aug; 40(8 Suppl):IV-49-54. PubMed ID: 12187168
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer.
Du X; Freeman JL; Warren JL; Nattinger AB; Zhang D; Goodwin JS
Med Care; 2000 Jul; 38(7):719-27. PubMed ID: 10901355
[TBL] [Abstract][Full Text] [Related]
7. Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Morton LM; Dores GM; Schonfeld SJ; Linet MS; Sigel BS; Lam CJK; Tucker MA; Curtis RE
JAMA Oncol; 2019 Mar; 5(3):318-325. PubMed ID: 30570657
[TBL] [Abstract][Full Text] [Related]
8. Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.
Engels EA; Pfeiffer RM; Ricker W; Wheeler W; Parsons R; Warren JL
Am J Epidemiol; 2011 Oct; 174(7):860-70. PubMed ID: 21821540
[TBL] [Abstract][Full Text] [Related]
9. Use of SEER-Medicare data for measuring cancer surgery.
Cooper GS; Virnig B; Klabunde CN; Schussler N; Freeman J; Warren JL
Med Care; 2002 Aug; 40(8 Suppl):IV-43-8. PubMed ID: 12187167
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
Gold HT; Do HT
Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
[TBL] [Abstract][Full Text] [Related]
11. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
[TBL] [Abstract][Full Text] [Related]
13. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
Kim HM; Goodman M; Kim BI; Ward KC
J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
[TBL] [Abstract][Full Text] [Related]
14. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.
Healy MA; Morris AM; Abrahamse P; Ward KC; Kato I; Veenstra CM
BMC Cancer; 2018 Apr; 18(1):481. PubMed ID: 29703172
[TBL] [Abstract][Full Text] [Related]
15. Utility of the SEER-Medicare data to identify chemotherapy use.
Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer.
Kent EE; Malinoff R; Rozjabek HM; Ambs A; Clauser SB; Topor MA; Yuan G; Burroughs J; Rodgers AB; DeMichele K
J Am Geriatr Soc; 2016 Jan; 64(1):186-92. PubMed ID: 26782871
[TBL] [Abstract][Full Text] [Related]
17. Underreporting of myeloid malignancies by United States cancer registries.
Craig BM; Rollison DE; List AF; Cogle CR
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):474-81. PubMed ID: 22237987
[TBL] [Abstract][Full Text] [Related]
18. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
Wang K; Sheets NC; Basak R; Chen RC
Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
[TBL] [Abstract][Full Text] [Related]
19. Assessment of Interstate Residential Mobility of SEER Patients: SEER and LexisNexis Residential Address Linkage.
Tatalovich Z; Stinchcomb DG; Mariotto A; Ng D; Stevens JL; Coyle LM; Penberthy L
J Registry Manag; 2022; 49(4):109-113. PubMed ID: 37260810
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Completeness of Managed Care Data to Identify Cancer Diagnoses and Treatments for Patients in the SEER-Medicare Data.
Warren JL; Parsons HM; Mariotto AB; Boyd E; Enewold L
Med Care; 2023 Dec; 61(12):846-857. PubMed ID: 37796197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]